{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:34:12Z","timestamp":1761896052160},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.acuro.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T07:13:52Z","timestamp":1433574832000},"page":"635-640","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Eficacia y seguridad del alprostadil intrauretral en pacientes con disfunci\u00f3n er\u00e9ctil refractarios al tratamiento mediante inhibidores de la 5-fosfodiesterasa"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"Garrido Abad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sinu\u00e9s Ojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Conde Caturla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fern\u00e1ndez Arjona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2015.04.007_bib0135","doi-asserted-by":"crossref","unstructured":"Hatzimouratidis K. Eardley I, Giuliano F, Moncada I, Salonia A. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. European Association of Urology 2015. [consultado 10 Ene 2015]. Disponible en: http:\/\/uroweb.org\/guideline\/male-sexual-dysfunction\/","DOI":"10.1016\/j.eururo.2015.06.014"},{"key":"10.1016\/j.acuro.2015.04.007_bib0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.acuro.2010.02.018","article-title":"Efectividad y satisfacci\u00f3n con el tratamiento en pacientes con disfunci\u00f3n er\u00e9ctil en Espa\u00f1a: Estudio EDOS","volume":"34","author":"Mart\u00edn Morales","year":"2010","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuro.2015.04.007_bib0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/diacare.26.3.777","article-title":"Vardenafil a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study","volume":"26","author":"Goldstein","year":"2003","journal-title":"Diabetes Care."},{"key":"10.1016\/j.acuro.2015.04.007_bib0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1743-6109.2006.00295.x","article-title":"Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction","volume":"3","author":"Ziegler","year":"2006","journal-title":"J Sex Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0155","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s00125-004-1549-6","article-title":"Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: Analysis of data from tadalafil clinical trials","volume":"47","author":"Fonseca","year":"2004","journal-title":"Diabetologia."},{"key":"10.1016\/j.acuro.2015.04.007_bib0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0090-4295(00)00659-2","article-title":"Sildenafil in the treatment of erectile dysfunction after radical prostatectomy","volume":"56","author":"Zagaja","year":"2000","journal-title":"Urology."},{"key":"10.1016\/j.acuro.2015.04.007_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0170","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","article-title":"EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction","volume":"53","author":"Althof","year":"1999","journal-title":"Urology."},{"key":"10.1016\/j.acuro.2015.04.007_bib0175","doi-asserted-by":"crossref","unstructured":"Sun L, Peng FL, Yu ZL, Liu CL, Chen J. Combined sildenafil with vacuum erection device therapy in the management of diabetic men with erectile dysfunction after failure of first-line sildenafil monotherapy. Int J Urol. 2014;21(12):1263-1267. Doi: 10.1111\/iju.12564. Epub 2014 Jul 14. Epub ahead of print.","DOI":"10.1111\/iju.12564"},{"key":"10.1016\/j.acuro.2015.04.007_bib0180","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.acuro.2015.04.007_bib0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4065\/84.2.139","article-title":"Erectile dysfunction and cardiovascular disease efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions","volume":"84","author":"Nehra","year":"2009","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.acuro.2015.04.007_bib0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1743-6109.2012.02885.x","article-title":"Standard operating precedure for the preservation of erectile function outcomes after radical prostatectomy","volume":"10","author":"Mulhall","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.acuro.2015.04.007_bib0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0090-4295(98)00525-1","article-title":"Treatment of erectile dysfunction with sildenafil","volume":"53","author":"Marks","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.04.007_bib0200","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1743-6109.2005.00150.x","article-title":"Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives","volume":"2","author":"Van Ahlen","year":"2005","journal-title":"J Sex Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0205","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.urology.2003.11.039","article-title":"Use of intraurethral alprostadil in patients not responding to sildenafil citrate","volume":"63","author":"Jaffe","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2015.04.007_bib0210","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1743-6109.2009.01364.x","article-title":"Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction","volume":"6","author":"Canvungen","year":"2009","journal-title":"J Sex Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2164\/jandrol.05035","article-title":"Combination therapy: Medicated uretrhral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy","volume":"26","author":"Raina","year":"2005","journal-title":"J Androl."},{"key":"10.1016\/j.acuro.2015.04.007_bib0220","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1464-410X.2000.00790.x","article-title":"Results from different patient populations using combined therapy with alprostadil and sildenafil: Predictors of satisfaction","volume":"86","author":"Mydlo","year":"2000","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2015.04.007_bib0225","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/sj.ijir.3900795","article-title":"Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy","volume":"4","author":"Nehra","year":"2002","journal-title":"Int J Impot Res."},{"key":"10.1016\/j.acuro.2015.04.007_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1743-6109.2011.02498.x","article-title":"Low-intensity extracorporeal shock wave therapy-a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy","volume":"9","author":"Gruenwald","year":"2012","journal-title":"J Sex Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0235","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/iju.12506","article-title":"Extracorporeal shockwave therapy in the treatment of erectile dysfunction: A prospective, randomized, double-blinded, placebo controlled study","volume":"21","author":"Yee","year":"2014","journal-title":"Int J Urol."},{"key":"10.1016\/j.acuro.2015.04.007_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil","volume":"336","author":"Padma-Natham","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.acuro.2015.04.007_bib0245","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0022-5347(01)62527-8","article-title":"Efficacy and safety of transuretral alprostadil in patients with erectile dysfunction following radical prostatectomy","volume":"160","author":"Costabile","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2015.04.007_bib0250","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.ijir.3901284","article-title":"Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis","volume":"17","author":"Raina","year":"2005","journal-title":"Int J Impot Res."},{"key":"10.1016\/j.acuro.2015.04.007_bib0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1464-410x.1998.00703.x","article-title":"Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction","volume":"81","author":"Williams","year":"1998","journal-title":"Br J Urol."},{"key":"10.1016\/j.acuro.2015.04.007_bib0260","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1111\/j.1743-6109.2011.02474.x","article-title":"Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events","volume":"8","author":"Rastrelli","year":"2011","journal-title":"J Sex Med."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480615001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480615001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T08:39:23Z","timestamp":1566808763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480615001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0210480615001588"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2015.04.007","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eficacia y seguridad del alprostadil intrauretral en pacientes con disfunci\u00f3n er\u00e9ctil refractarios al tratamiento mediante inhibidores de la 5-fosfodiesterasa","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AEU. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}